Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4209 (112th)

Patients' Access to Treatments Act of 2012

referredUnited States· United States Congress· EN

Introduced

19 March 2012

Last action

19 March 2012 · Introduced

Status

Referred to the House Committee on Energy and Commerce.

Sponsors

Rep. McKinley, David B. [R-WV-1], Rep. Capps, Lois [D-CA-24], Rep. Young, C. W. Bill [R-FL-13], Rep. Cuellar, Henry [D-TX-28], Rep. Frank, Barney [D-MA-4], Rep. Harper, Gregg [R-MS-3], Rep. McGovern, James P. [D-MA-2], Rep. Conyers, John, Jr. [D-MI-13], Rep. Rothman, Steven R. [D-NJ-9], Rep. Deutch, Theodore E. [D-FL-22], Rep. Bartlett, Roscoe G. [R-MD-6], Rep. Farr, Sam [D-CA-20], Rep. Crenshaw, Ander [R-FL-4], Rep. Bonner, Jo [R-AL-1], Rep. Jackson, Jesse L., Jr. [D-IL-2], Rep. Pingree, Chellie [D-ME-1], Rep. Bachus, Spencer [R-AL-6], Rep. Tonko, Paul [D-NY-20], Rep. Roybal-Allard, Lucille [D-CA-40], Rep. Langevin, James R. [D-RI-2], Rep. Young, Don [R-AK-At Large], Rep. Cicilline, David N. [D-RI-1], Rep. Moran, James P. [D-VA-8], Rep. Davis, Susan A. [D-CA-53], Rep. Johnson, Henry C. "Hank" [D-GA-4], Rep. Holt, Rush [D-NJ-12], Rep. Courtney, Joe [D-CT-2], Rep. Boswell, Leonard L. [D-IA-3], Rep. Gerlach, Jim [R-PA-6], Rep. Woolsey, Lynn C. [D-CA-6], Rep. Pastor, Ed [D-AZ-4], Rep. Wolf, Frank R. [R-VA-10], Rep. Runyan, Jon [R-NJ-3], Rep. Rangel, Charles B. [D-NY-15], Rep. Michaud, Michael H. [D-ME-2], Sen. Capito, Shelley Moore [R-WV], Rep. Davis, Danny K. [D-IL-7], Rep. Towns, Edolphus [D-NY-10], Sen. Markey, Edward J. [D-MA], Rep. Bishop, Timothy H. [D-NY-1], Rep. Bonamici, Suzanne [D-OR-1], Rep. McDermott, Jim [D-WA-7], Sen. Welch, Peter [D-VT], Rep. DeFazio, Peter A. [D-OR-4]

Subjects

Healthcare

Source updated

14 August 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Patients' Access to Treatments Act of 2012 - Amends the Public Health Service Act to prohibit a health plan offering group or individual health insurance that provides coverage for prescription drugs and uses a formulary or other tiered cost-sharing structure from imposing co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier that exceed the dollar amount of such requirements applicable to prescription drugs in a non-preferred brand drug tier. Provides that if a formulary used by such a health plan contains more than one non-preferred brand drug tier, such prohibition shall be applied with respect to the non-preferred brand drug tier for which beneficiary cost-sharing is lowest. Defines: (1) "non-preferred brand drug tier" as a category of drugs within a tier in such formulary for which beneficiary cost-sharing is greater than tiers for generic drugs or preferred brand drugs in the plan's formulary, that are prescription drugs, and that are not included within a specialty drug tier; and (2) "specialty drug tier" as a category of drugs within a tier in such formulary for which beneficiary cost-sharing is greater than tiers for generic drugs, preferred brand drugs, or non-preferred drugs in the plan's formulary and that are prescription drugs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 19 March 2012

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 19 March 2012

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 19 March 2012

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 19 March 2012

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 19 March 2012

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 19 March 2012

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.